Somewhat Positive Press Coverage Somewhat Unlikely to Affect Affymetrix (AFFX) Stock Price
News articles about Affymetrix (NASDAQ:AFFX) have been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Affymetrix earned a news sentiment score of 0.12 on Accern’s scale. Accern also assigned media coverage about the scientific and technical instruments company an impact score of 45.8766201160371 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
Affymetrix (AFFX) traded up $0.02 during trading on Monday, reaching $14.01. 5,030,400 shares of the company were exchanged, compared to its average volume of 3,494,434. Affymetrix has a 52 week low of $8.28 and a 52 week high of $16.15.
ILLEGAL ACTIVITY NOTICE: “Somewhat Positive Press Coverage Somewhat Unlikely to Affect Affymetrix (AFFX) Stock Price” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece on another site, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this piece can be viewed at https://www.thecerbatgem.com/2017/11/20/somewhat-positive-press-coverage-somewhat-unlikely-to-affect-affymetrix-affx-stock-price-2.html.
Affymetrix, Inc (Affymetrix) is a provider of life science products and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein and cell level. The Company operates through two business segments: Affymetrix Core and eBioscience. The Affymetrix Core segment focuses on the development, manufacture and commercialization of systems for genetic analysis in the life sciences, agricultural biotechnology (AgBio) and diagnostic industry.
Receive News & Stock Ratings for Affymetrix Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Affymetrix Inc. and related stocks with our FREE daily email newsletter.